Dr. Reddy’s Of India To Withdraw From Small Markets
This article was originally published in PharmAsia News
Executive Summary
India's Dr. Reddy's Laboratories plans to abandon small pharmaceutical markets around the world and concentrate on larger ones. According to Dr. Reddy's, the small markets account for less than one percent of the generics maker's revenues. A company spokesman said the withdrawal already is occurring in some countries across all regions of the world. Managing Director and COO Satish Reddy said the move is being made so the firm can be more assertive in key markets, redeploying its resources accordingly. The firm counts the United States, India, Russia, former Soviet republics and Germany as contributing 90 percent of its global revenues. (Click here for more